Rezolute (RZLT) Interest & Investment Income (2012 - 2026)
Rezolute (RZLT) posted Interest & Investment Income of -$162000.0 for Q1 2026, down 111.2% sequentially from $1.4 million in Q4 2025, and down 671.43% YoY from $28350.0 in Q1 2025.
Rezolute (RZLT) Interest & Investment Income (2012 - 2026) Analysis & Trends
Rezolute has reported Interest & Investment Income for 15 years, with the latest figure at -$162000.0 in Q1 2026.
- Quarterly Interest & Investment Income fell 671.43% year-over-year to -$162000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.8 million (down 55.69% YoY) and the FY2025 annual result came in at $5.5 million, up 12.57% from the prior year.
- Interest & Investment Income retreated to -$162000.0 in Q1 2026 per RZLT's latest filing, from $1.4 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $4.6 million in Q2 2024 and troughed at -$162000.0 in Q1 2026.
- A 5-year average of $1.1 million and a median of $624500.0 in 2022 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2022 and 2026: Interest & Investment Income soared 6600.0% in 2022, then plunged 671.43% in 2026.
- Over 5 years, Interest & Investment Income stood at $849000.0 in 2022, then soared by 53.47% to $1.3 million in 2023, then increased by 3.15% to $1.3 million in 2024, then grew by 7.66% to $1.4 million in 2025, then plunged by 111.2% to -$162000.0 in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered -$162000.0, $1.4 million, and $56000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 48.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 35.58 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 27.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 5.13 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 28.14 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Rezolute | 442.94 Mn | 442.94 Mn | - | -162,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -162,000.00 |
| Dec 31, 2025 | 1.45 Mn |
| Sep 30, 2025 | 56,000.00 |
| Jun 30, 2025 | 1.45 Mn |
| Mar 31, 2025 | -21,000.00 |
| Dec 31, 2024 | 1.34 Mn |
| Sep 30, 2024 | 368,000.00 |
| Jun 30, 2024 | 4.60 Mn |
| Mar 31, 2024 | -30,000.00 |
| Dec 31, 2023 | 1.30 Mn |
| Sep 30, 2023 | 1.40 Mn |
| Jun 30, 2023 | 4.34 Mn |
| Mar 31, 2023 | -132,000.00 |
| Dec 31, 2022 | 849,000.00 |
| Sep 30, 2022 | 400,000.00 |
| Jun 30, 2022 | 67,000.00 |
| Dec 31, 2021 | 13,000.00 |
| Jun 30, 2021 | 1,000.00 |
| Mar 31, 2021 | 4,000.00 |
| Dec 31, 2020 | 55,000.00 |